Tim Loh

Bloomberg

Medical personnel collect a sample from a patient at a drive-thru COVID-19 testing clinic at a Kaiser Permanente facility in San Francisco on March 12, 2020.

U.S. gives ’emergency’ authorization to new Roche coronavirus test that’s 10 times faster

/2020/03/13/fda-emergency-authorization-roche-coronavirus-test/

The CEO of German chemicals giant Bayer, Werner Baumann, speaks during the company's annual news conference in Leverkusen, western Germany, on February 27, 2020. - German chemical and pharmaceutical giant Bayer reported surging profits for 2019 after its buying US seeds and pesticides maker Monsanto, but remained entangled in a massive wave of lawsuits over a flagship weedkiller. (Photo by Ina FASSBENDER / AFP) (Photo by INA FASSBENDER/AFP via Getty Images)

Bayer says Roundup legal fiasco may force it to sell assets or borrow on bad terms

/2020/02/27/bayer-roundup-lawsuits-sell-assets-earnings/

Jef Feeley

Roundup weed killer is the subject of thousands of lawsuits in the U.S. It has been blamed for ailments including non-Hodgkin’s lymphoma, which can take years to diagnose.

Bayer may pay $10 billion to settle Roundup cancer cases from its Monsanto deal

/2020/01/24/bayer-pay-10-billion-roundup-cancer-cases-monsanto/

Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California on September 1, 2019. (Photo by Mark RALSTON / AFP) (Photo credit should read MARK RALSTON/AFP/Getty Images)

Bayer’s $30 Billion Roundup Crisis Heats Up as It Braces for a ‘Significant Surge’ of New Lawsuits

/2019/10/16/bayer-monsanto-roundup-crisis-new-lawsuits/

Joel Rosenblatt

Bayer Wants to Settle All Roundup-Related Cancer Claims for $8 Billion

/2019/08/09/bayer-settlement-roundup-cancer/

Adidas CEO said a currency war would hurt the brand more than tariffs.

Adidas Boss Warns Currency War Will Hurt More Than Tariffs

/2019/08/08/adidas-currency-war-tariffs-us-china-trade/

‘The Jump Is Worrying’: Bayer Reports Even More Roundup-Related Cancer Lawsuits

/2019/07/30/bayer-earnings-roundup-cancer-lawsuits/

Naomi Kresge

Bayer AG Holds Annual Shareholders Meeting

Bayer Commits $5.6 Billion to Glyphosate Alternatives Amid 13,000 Lawsuits Over the Weedkiller

/2019/06/14/bayer-glyphosate-roundup-lawsuits/

Why Adidas Shares Are Soaring

/2019/05/03/adidas-stock-q1/

$80 Million Awarded To Man In Roundup Exposure Case

Bayer Gets Temporary Relief from Its Monsanto-Roundup Woes

/2019/04/25/bayer-q1-earnings-monsanto-roundup/

Pipette adding sample to petri dish with DNA profiles in background

Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist Spark

/2019/02/25/roche-gene-therapy-spark/

https://fortune.com/author/tim-loh/

Page 3 of 3: Stay informed with Tim Loh’s coverage and analysis for Fortune.

Stay informed with Tim Loh’s coverage and analysis for Fortune.